38.86

0.47% -0.26

Twist Bioscience Corp (TWST)

Overview News Price History Option Chain Financials Discussions Forecast

Twist Bioscience Corp stock is traded at $38.86, with a volume of 206.25K. It is down -0.47% in the last 24 hours and up +13.02% over the past month. Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Previous Close:

$39.12

Open:

$39.2

24h Volume:

206.25K

Relative Volume:

0.17

Market Cap:

$2.06B

Revenue:

$277.49M

Net Income/Loss:

$-192.14M

P/E Ratio:

-11.57

EPS:

-3.36

Net Cash Flow:

$-95.52M

1W Performance:

+2.00%

1M Performance:

+13.02%

6M Performance:

-10.70%

1Y Performance:

-23.64%

1-Day Range:

$38.36

$39.37

1-Week Range:

$35.44

$39.37

52-Week Range:

$27.12

$60.90

Twist Bioscience Corp Stock (TWST) Company Profile

Name

Twist Bioscience Corp

Sector

Healthcare (1166)

Industry

Diagnostics & Research (54)

Phone

800-719-0671

Address

681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA

Employee

923

Twitter

@TwistBioscience

Next Earnings Date

2025-02-03

Latest SEC Filings

TWST's Discussions on Twitter

Compare TWST with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TWST Twist Bioscience Corp	38.94	2.06B	277.49M	-192.14M	-95.52M	-3.36
TMO Thermo Fisher Scientific Inc	437.47	156.49B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	207.83	145.01B	23.82B	3.77B	4.90B	5.15
IDXX Idexx Laboratories Inc	548.22	42.30B	3.93B	894.97M	837.70M	10.82
A Agilent Technologies Inc	126.16	34.24B	6.63B	1.17B	1.19B	4.05
IQV Iqvia Holdings Inc	168.82	27.64B	15.50B	1.33B	2.16B	7.34

Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-13-24	Initiated	Wolfe Research	Outperform
Jun-04-24	Initiated	Guggenheim	Buy
Jan-17-24	Upgrade	Goldman	Neutral → Buy
Sep-27-23	Initiated	Berenberg	Buy
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-03-23	Upgrade	Evercore ISI	In-line → Outperform
Mar-02-22	Resumed	Cowen	Outperform
Oct-15-21	Resumed	Cowen	Outperform
Jun-29-21	Initiated	William Blair	Outperform
Jun-04-21	Initiated	Goldman	Neutral
Apr-12-21	Initiated	Piper Sandler	Overweight
Feb-05-21	Downgrade	JP Morgan	Neutral → Underweight
Jan-04-21	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-20	Initiated	SVB Leerink	Mkt Perform
May-31-19	Initiated	Evercore ISI	Outperform
Nov-26-18	Initiated	JP Morgan	Neutral

View All

Twist Bioscience Corp Stock (TWST) Latest News

Jun 16, 2025

Here's Why We're Not At All Concerned With Twist Bioscience's (NASDAQ:TWST) Cash Burn Situation - Yahoo Finance

Jun 16, 2025

Twist Bioscience Co. (NASDAQ:TWST) Shares Purchased by Handelsbanken Fonder AB - Defense World

Jun 16, 2025

Twist Bioscience Co. (NASDAQ:TWST) Shares Acquired by GAMMA Investing LLC - Defense World

Jun 16, 2025

Jun 15, 2025

Rhumbline Advisers Increases Stock Holdings in Twist Bioscience Co. (NASDAQ:TWST) - Defense World

Jun 15, 2025

Jun 11, 2025